James David Clark
SVP, Cont & Chief Acct Officer
Common Stock (Restricted)
- Value context
- $41.3K
- Reported price
- $90.98 / share
CVS HEALTH Corp
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
SVP, Cont & Chief Acct Officer
Common Stock (Restricted)
EVP, Chief Financial Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP, Chief Medical Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Common Stock
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP and Group President
Common Stock (Restricted)
EVP and Group President
Common Stock
EVP and Group President
Stock Option
Derivative security · not the ordinary share price.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| SVP, Cont & Chief Acct Officer | Common Stock (Restricted)Exercise-price or tax withholding | 454$90.98 / share | $41.3K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| EVP, Chief Financial Officer | Common StockExercise-price or tax withholding | 2,478$90.98 / share | $225.45K | May 31Filed Jun 1 · 1d later | SEC filing |
| EVP, Chief Medical Officer | Common StockExercise-price or tax withholding | 7,618$90.98 / share | $693.09K | May 31Filed Jun 1 · 1d later | SEC filing |
| Director | Common StockDisposition to issuer | 30,437$93.78 / share | $2.85M | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockDisposition to issuer | 1,563$93.50 / share | $146.14K | May 21Filed May 22 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,448$97.15 / derivative unit | $140.63K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,737$97.15 / derivative unit | $168.75K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,563$97.15 / share | $151.85K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 2,058$97.15 / share | $199.93K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,447$97.15 / share | $140.58K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,447$97.15 / share | $140.58K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,447$97.15 / share | $140.58K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,448$97.15 / derivative unit | $140.63K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,544$97.15 / derivative unit | $150K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,544$97.15 / share | $150K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,448$97.15 / derivative unit | $140.63K | May 14Filed May 15 · 1d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units1,930$97.15 / derivative unit | $187.5K | May 14Filed May 15 · 1d later | SEC filing |
| EVP and Group President | Common Stock (Restricted)Grant or award | 25,062$71.82 / share | $1.8M | Mar 31Filed Apr 2 · 2d later | SEC filing |
| EVP and Group President | Common StockExercise-price or tax withholding | 1,484$72.49 / share | $107.58K | Apr 1Filed Apr 2 · 1d later | SEC filing |
| EVP and Group President | Stock OptionGrant or award | Derivative units161,676$71.82 / derivative unit | $11.61M | Mar 31Filed Apr 2 · 2d later | SEC filing |
Showing the latest 20 of 41 trades. Show all 41 trades
CVS Health Corporation Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberCVS Health Corporation Common Stock · Stock
The filing reports a purchase for the member.
CVS Health Corporation Common Stock (CVS) · Stock
The filing reports a partial sale for the member.
Dwight EvansReporting House memberCVS Corp · Stock
The filing reports a purchase for a joint account.
John BoozmanReporting Senate memberCVS Health Corporation Common Stock (CVS) · Stock
The filing reports a sale for the member.
Dwight EvansReporting House memberCVS Health Corporation Common Stock (CVS) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberCVS Health Corporation Common Stock (CVS) · Stock
The filing reports a purchase for a spouse.
Lisa McClainReporting House memberCVS Health Corporation Common Stock (CVS) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberCVS Health Corporation Common Stock (CVS) · Stock
The filing reports a sale for a spouse.
Valerie HoyleReporting House member